The North America cytomegalovirus treatment market is expanding due to increasing awareness of CMV infections, advanced transplant care, and the availability of established antiviral therapies. Growing demand for effective prophylaxis and treatment among high-risk patients is encouraging pharmaceutical innovation and specialized clinical management. The region's sophisticated healthcare...